Cutler Group’s Privia Health PRVA Stock Holding History

Cutler Group’s Portfolio PRVA Stock Details PRVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,400	Closed	-$2K	–	5031
2022 Q3	$2K	Buy	+1,400	New	+$51.8K	﹤0.01%	4271

Other funds holding PRVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Cutler Group's PRVA Position: Q4 2023 in Review

Cutler Group sold out of Privia Health (PRVA) in Q4 2023, closing a stake of 1 share.

Cutler Group first reported a position in PRVA in Q3 2022 and held it in 2 quarters. The position peaked at $10K in Q3 2022. 226 funds tracked by Wall St. Rank hold PRVA as of Q4 2023.

Cutler Group reported no remaining Privia Health position as of Q4 2023 after selling out during the quarter.
Cutler Group sold 1 Privia Health share in Q4 2023.
Cutler Group first reported a position in Privia Health in Q3 2022 and held it in 2 quarters.
Cutler Group's Privia Health position peaked at $10K in Q3 2022.
226 funds tracked by Wall St. Rank held Privia Health as of Q4 2023.

Based on Cutler Group's 13F filing for Q4 2023, filed 18 Jan 2024.